Browse wide-ranging research at the frontiers of neuroscience supported by Wu Tsai Neurosciences Institute grants, awards, and training fellowships.
Projects
Structural and mechanistic analysis of the protein-protein interface between ABCA1 and ApoE as a potential therapeutic target for Alzheimer’s Disease
We propose a new line of research whose goal is to examine the druggability of a protein-protein interface involving ApoE, an apolipoprotein whose gene variants represent the strongest genetic risk factor for AD.
Dissecting mechanisms of gut-brain communication in Parkinson’s Disease
People with Parkinson’s Disease (PD) have different types of bacteria in their guts compared to people without neurological diseases. We will study which gut bacteria for people with PD to gain a better understanding of how gut bacteria contribute to inflammation in the body and in the brain or people with this condition.
Novel ketone-derived anticonvulsant agents for the treatment of childhood refractory epilepsy
We propose to apply mass spectrometry techniques to measure BHB-Phe and other KD metabolites in children undergoing KD for refractory epilepsy at Stanford. Further, in a mouse model of refractory genetic epilepsy, we will compare targeted BHB-Phe treatment to full KD treatment using transcriptomics, EEG assessment of seizures and cognitive testing.
Life-long, minimally invasive, and multiplex transcriptional profiling of the cerebellum
Why do all our brains mature and age in different ways, leading to different cognitive and behavioral outcomes? We envision a novel method that “copies” the information from the RNAs made by the neurons to sensor RNAs we artificially introduce into live animals.
Use of gut-brain electrophysiology to study interoception in eating disorders
In this study, we aim to (i) perform a feasibility study to determine the acceptance and feasibility of performing such recordings in the AN and ARFID eating disorders population and (ii) test the hypothesis that the electrophysiologic monitoring of the brain and stomach is associated with a clinically validated behavioral measure of interoception involving water distention of the stomach.
In vivo selection for gene mutations that counteract photoreceptor degeneration
A novel PET radioligand to identify microglial inflammation in Alzheimer's disease
A novel sigma-1 receptor PET radioligand as a probe of ketamine’s rapid therapeutic action in disorders of human brain and behavior: Pilot study
The impact of early medial temporal lobe Tau in human cognitive aging
Sensory processing in a pre-seizure state
Investigating the role of a human-specific repeat element in neuropsychiatric disease risk and cerebellar function
Quantifying auditory-vocal affect in human social communication
This proposal brings together faculty with this diverse expertise to develop the first gold standard test of auditory-vocal affect. Once developed, validated, and normed, we will deploy this test in the clinical context of autism to quantify impairments and direct neurobiological investigation.
Mapping the Mitophagy Network in Parkinson’s Disease
We will comprehensively define the gene network associated with mitochondrial dysfunction in Parkinson's disease using a cutting-edge technology, CRISPR, to understand how these nerve cells die in PD and how we can reverse the cell death to treat the disease.
Inflammation, Major Histocompatibility Class I and human brain development
Maternal infection is linked to increased risk of neurodevelopmental disorders such as autism and schizophrenia. This proposal examines how virus-associated cytokines, specifically interferons, affect human neurons modeled in brain organoids or studied directly in fetal brain samples.